Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2003

View Archived Issues

Sertraline reported to improve major depression in patients with AD

Sepracor updates status of key clinical development programs

New factor XIIIa inhibitors prepared and tested at Curacyte

Antimitotic drugs in early development at Pfizer

Sumitomo presents new 5-HT reuptake inhibitors/5-HT1A agonists

Novel peripheral BZ receptor ligands with neurotrophic activity claimed by Sanofi-Synthelabo

SCRAS scientists design new inhibitors of protein phosphatases

Radiolabeled Ab fragments and their use as angiogenesis markers in cancer diagnosis and treatment

Neurogen updates pipeline status

Abbott and LigoCyte enter collaboration for antiinflammatory monoclonal antibody

Preliminary PRIMO-CABG results reported

Allos Therapeutics commences rolling NDA submission for RSR-13

Norak acquires ChemFolio compound library

ISTA files second Vitrase NDA

Collaborative Study Group to conduct KRX-101 phase II/III program

Prana selects PBT-2 for development for Alzheimer's disease

New phase II trial evaluates NicVAX in smokers

aaiPharma and CIMA to merge

Small-molecule inhibitors of c-Met pursued at Sugen as potential anticancer agents

Lilly to use Serenex chemoproteomics technologies for screening

Bimosiamose decreases LAR in asthmatics following allergen challenge

Genome Therapeutics expands ramoplanin development program

Design of dual Src/Abl tyrosine kinase inhibitors with antitumor and antimetastatic activity

New agent with dual radiosensitizing and cytotoxic activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...